LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1HRV Global Life Sciences
03 1Alembic Pharmaceuticals Limited
04 1Apotex Pharmachem
05 1Aspire Lifesciences Pvt Ltd
06 1Aurobindo Pharma Limited
07 1Biotechnica DWC
08 1Cipla
09 1Dalian Richon Chem
10 1Emcure Pharmaceuticals
11 1Enaltec Labs Private Limited
12 1Glenmark Life Sciences
13 1Haoyuan Chemexpress Co.Ltd
14 1Hetero Drugs
15 1Jubilant Generics
16 1Jubilant Pharmova
17 1MSN Laboratories
18 1Macleods Pharmaceuticals Limited
19 1Megafine Pharma (P) Limited
20 1Par Pharmaceutical
21 1Shodhana Laboratories Pvt. Ltd
22 1Shouyuan Chemical
23 1Teva API
24 1Teva Pharmaceutical Industries
25 1Torrent Pharmaceuticals Limited
26 1Unimark Remedies Limited
27 1Viatris
01 1Algeria
02 1Canada
03 3China
04 17India
05 2Israel
06 3U.S.A
01 13Active
02 2Inactive
03 12Blank
01 27Blank
01 27Blank
01 1WC-0022
02 1WC-0023
03 1WC-0057n
04 1WC-0066
05 1WC-0079
06 1WC-0082
07 1WC-0087-(Annexure-1)
08 1WC-0092
09 1WC-0142
10 18Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-06-03
Pay. Date : 2012-12-11
DMF Number : 22225
Submission : 2008-11-21
Status : Active
Type : II
Date of Issue : 2019-08-16
Valid Till : 2025-08-15
Written Confirmation Number : WC-0022
Address of the Firm :
NDC Package Code : 50370-0007
Start Marketing Date : 2010-04-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-07-23
Pay. Date : 2013-03-20
DMF Number : 26533
Submission : 2012-09-30
Status : Active
Type : II
Date of Issue : 2022-07-27
Valid Till : 2025-07-21
Written Confirmation Number : WC-0087-(Annexure-1)
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-08-21
Pay. Date : 2012-12-06
DMF Number : 25530
Submission : 2011-12-08
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23269
Submission : 2009-11-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22184
Submission : 2008-11-17
Status : Active
Type : II
Date of Issue : 2022-06-07
Valid Till : 2025-06-25
Written Confirmation Number : WC-0057n
Address of the Firm :
NDC Package Code : 66039-861
Start Marketing Date : 2008-11-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-08-28
Pay. Date : 2013-08-14
DMF Number : 22206
Submission : 2008-11-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22371
Submission : 2008-12-27
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26419
Submission : 2012-09-27
Status : Inactive
Type : II
We have 27 companies offering Darifenacin Hydrobromide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?